News
Astellas' Iveric takeover rewarded with FDA nod for GA drug
The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company
News
Zuranolone cleared for post-partum depression, but not MDD
Biogen and Sage Therapeutics' zuranolone has become the first oral drug to be approved by the FDA for post-partum depression (PPD), but the US regulator turned down a requ
News
AZ, Sanofi's Beyfortus gets CDC okay for RSV prevention
The final obstacle to the routine use of Sanofi and AstraZeneca's Beyfortus to prevent respiratory syncytial virus (RSV) in the US has fallen after it was backed by Centre
News
NICE unconvinced by CSL's haemophilia B gene therapy
The UK's National Institute for Health and Care Excellence (NICE) has said it is minded not to recommend approval of CSL Behring and uniQure's Hemgenix gene therapy for ha
News
Samsung seeks 'interchangeable' label for Humira biosimilar
While there are already a number of biosimilars of AbbVie's big-selling Humira on the US market, so far, only one – Boehringer Ingelheim's
Editor's Picks
Editor's Picks
